MediFind
LoginSign Up
Are we missing a condition or feature you’d like to see? MediFind is always evolving and we’d love your feedback.
MediFind
Condition

Minimal Change Disease

Symptoms, Doctors, Treatments, Research & More

Active Clinical Trials

Clinical Trial
Other
  • Status: Not yet recruiting
  • Study Type: Other
  • Participants: 375
  • Start Date: October 31, 2020
Nephrotic Syndrome Study Network (NEPTUNE) Match Study
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 125
  • Start Date: July 28, 2020
A Phase 2a Multiple Ascending, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GFB-887, a TRPC5 Channel Inhibitor, in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease
Clinical Trial
Other
  • Status: Recruiting
  • Participants: 3000
  • Start Date: May 5, 2020
Global Kidney Patient Trials Network
Clinical Trial
Drug
  • Status: Active, not recruiting
  • Study Type: Drug
  • Participants: 148
  • Start Date: January 14, 2020
Rituximab From the First Episode of Minimal Change Nephrotic Syndrome for Preventing Relapse Risk in Adult Patients: a Multicenter Randomized Controlled Trial
Clinical Trial
Device
  • Status: Recruiting
  • Study Type: Device
  • Participants: 30
  • Start Date: December 1, 2019
Effect of Daily Transcutaneous Auricular Vagus Nerve (taVNS) Stimulation on Proteinuria in Pediatric Patients With Idiopathic Nephrotic Syndrome
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 8
  • Start Date: October 2, 2019
Precision Medicine Proof of Concept for Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change Disease
Clinical Trial
Other
  • Status: Recruiting
  • Participants: 30
  • Start Date: September 1, 2019
Efficacy and Safety of Rituximab in Adult Patients With Refractory or Relapsed Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
Clinical Trial
Other
  • Status: Recruiting
  • Study Type: Other
  • Participants: 3000
  • Start Date: May 1, 2019
Multicenter Prospective Cohort of Kidney Biopsy for Glomerular Disease Research
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 40
  • Start Date: August 22, 2018
Efficacy of Rituximab in Comparison to Continued Corticosteroid Treatment in Idiopathic Nephrotic Syndrome Unresponsive to 8 Weeks of High Dose Prednisone
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 96
  • Start Date: May 1, 2018
Treatment of Primary Minimal Change Nephropathy: A Randomized Open-labeled Non-inferiority Study on Prednisolone and Vitamin D
Clinical Trial
Other
  • Status: Recruiting
  • Study Type: Other
  • Participants: 500
  • Start Date: April 1, 2018
The FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)
Clinical Trial
Genetic
  • Status: Active, not recruiting
  • Study Type: Genetic
  • Participants: 150
  • Start Date: October 2016
Study of The Association of Mutations in The NPHS2 Gene and Nephrotic Syndrome in Children and Adults in Middle East
Showing 1–12 of 16 Clinical Trials
Next